Zobrazeno 1 - 10 of 33 pro vyhledávání: '"Berthe M P Aleman"'
1
Akademický článek
Effectiveness and Cost-Effectiveness of Survivorship Care for Survivors of Hodgkin Lymphoma (INSIGHT Study): Protocol for a Multicenter Retrospective Cohort Study With a Quasi-Experimental Design
Autor: Eline M J Lammers, Josée M Zijlstra, Valesca P Retèl, Berthe M P Aleman, Flora E van Leeuwen, Annelies Nijdam
Publikováno v: JMIR Research Protocols, Vol 13, p e55601 (2024)
BackgroundHodgkin lymphoma (HL) occurs at young ages, with the highest incidence between 20 and 40 years. While cure rates have improved to 80%-90% over the past decades, survivors of HL are at substantial risk of late treatment–related complicatio
Externí odkaz: https://doaj.org/article/96733ba3b3c14f89b8567a50ad39b2a8
Zobrazit plný text záznamu
2
Akademický článek
Gene expression profiles of esophageal squamous cell cancers in Hodgkin lymphoma survivors versus sporadic cases.
Autor: Berbel L M Ykema, Sanne J M Hoefnagel, Lisanne S Rigter, Liudmila L Kodach, Gerrit A Meijer, Flora E van Leeuwen, Hina N Khan, Petur Snaebjornsson, Berthe M P Aleman, Annegien Broeks, Sybren L Meijer, Kenneth K Wang, Beatriz Carvalho, Kausilia K Krishnadath, Monique E van Leerdam, GIOCA-OES
Publikováno v: PLoS ONE, Vol 15, Iss 12, p e0243178 (2020)
Hodgkin lymphoma (HL) survivors are at increased risk of developing second primary esophageal squamous cell cancer (ESCC). We aimed to gain insight in the driving events of ESCC in HL survivors (hESCC) by using RNA sequencing and NanoString profiling
Externí odkaz: https://doaj.org/article/2ac4dd9456fd435a9420b4fa0e7b5ef2
Zobrazit plný text záznamu
3
Akademický článek
Fatigue level changes with time in long-term Hodgkin and non-Hodgkin lymphoma survivors: a joint EORTC-LYSA cross-sectional study
Autor: Raphaël Busson, Marleen van der Kaaij, Nicolas Mounier, Berthe M. P. Aleman, Catherine Thiéblemont, Aspasia Stamatoullas, Vincent Ribrag, Hervé Tilly, Corinne Haioun, René-Olivier Casasnovas, Hanneke C. Kluin-Nelemans, Michel Henry-Amar
Publikováno v: Health and Quality of Life Outcomes, Vol 17, Iss 1, Pp 1-13 (2019)
Abstract Background Long-term lymphoma survivors often complain of persistent fatigue that remains unexplained. While largely reported in Hodgkin lymphoma (HL), long-term fatigue is poorly documented in non-Hodgkin lymphomas (NHL). Data collected in
Externí odkaz: https://doaj.org/article/ae5f7853b2e3475eb0340f83e61a3688
Zobrazit plný text záznamu
4
Comparison of outcomes between Hodgkin's lymphoma patients treated in and outside clinical trials
Autor: Sidsel Jacobsen Juul, Michal Kicinski, Michael Schaapveld, Sára Rossetti, Berthe M. P. Aleman, Lifang Liu, Flora E. van Leeuwen, Paul Meijnders, Augustinus D. G. Krol, Cécile P. M. Janus, Martin Hutchings, Maja V. Maraldo
Publikováno v: European journal of haematology
European Journal of Haematology, 110(3), 243-252. Wiley-Blackwell Publishing Ltd
European Journal of Haematology. WILEY
European Journal of Haematology
Studies have shown higher survival rates for patients with Hodgkin lymphoma (HL) treated within clinical trials compared to patients treated outside clinical trials. However, endpoints are often limited to overall survival (OS). In this retrospective
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de6610215917223497f76be630a172e6
https://doi.org/10.1111/ejh.13899
Zobrazit plný text záznamu
5
Cost-Effectiveness of Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors Treated with Procarbazine and/or Infradiaphragmatic Radiotherapy
Autor: Berbel L M, Ykema, Andrea, Gini, Lisanne S, Rigter, Manon C W, Spaander, Leon M G, Moons, Tanya M, Bisseling, Jan Paul, de Boer, Wieke H M, Verbeek, Pieternella J, Lugtenburg, Cecile P M, Janus, Eefke J, Petersen, Judith M, Roesink, Richard W M, van der Maazen, Berthe M P, Aleman, Gerrit A, Meijer, Flora E, van Leeuwen, Petur, Snaebjornsson, Beatriz, Carvalho, Monique E, van Leerdam, Iris, Lansdorp-Vogelaar
Publikováno v: Cancer Epidemiology, Biomarkers & Prevention, 31, 12, pp. 2157-2168
Cancer Epidemiology, Biomarkers & Prevention, 31, 2157-2168
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 31(12), 2157-2168. American Association for Cancer Research Inc.
Background: Hodgkin lymphoma survivors treated with infradiaphragmatic radiotherapy (IRT) and/or procarbazine have an increased risk of developing colorectal cancer. We investigated the cost-effectiveness of colorectal cancer surveillance in Dutch Ho
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fac7b7c10c302dcc4788c8daa9c7e21
http://www.scopus.com/inward/record.url?scp=85143379645&partnerID=8YFLogxK
Zobrazit plný text záznamu
8
Breast cancer and cardiovascular outcomes after breast cancer in survivors of Hodgkin lymphoma
Autor: Inge M. Krul, Naomi B. Boekel, Iris Kramer, Cécile P. M. Janus, Augustinus D. G. Krol, Marten R. Nijziel, Josée M. Zijlstra, Richard W. M. van der Maazen, Judith M. Roesink, Judy N. Jacobse, Michael Schaapveld, Marjanka K. Schmidt, Annemieke W. J. Opstal‐van Winden, Gabe S. Sonke, Nicola S. Russell, Berthe M. P. Aleman, Flora E. van Leeuwen
Publikováno v: Krul, I M, Boekel, N B, Kramer, I, Janus, C C P M, Krol, A D G, Nijziel, M R, Zijlstra, J M, van der Maazen, R W M, Roesink, J M, Jacobse, J N, Schaapveld, M, Schmidt, M K, Opstal-van Winden, A W J, Sonke, G S, Russell, N S, Aleman, B M P & van Leeuwen, F E 2022, ' Breast cancer and cardiovascular outcomes after breast cancer in survivors of Hodgkin lymphoma ', Cancer, vol. 128, no. 24, pp. 4285-4295 . https://doi.org/10.1002/cncr.34464
Cancer, 128(24), 4285-4295. John Wiley and Sons Inc.
Cancer, 128, 24, pp. 4285-4295
Cancer, 128(24), 4285-4295. John Wiley & Sons Inc.
Cancer, 128, 4285-4295
Item does not contain fulltext BACKGROUND: Hodgkin lymphoma (HL) survivors treated with chest radiotherapy have an increased risk of breast cancer (BC). Prior HL treatment and associated cardiovascular disease (CVD) risk may limit BC treatment option
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18db0c48634e273ea8baca4b4d793795
https://research.vumc.nl/en/publications/13227e25-fb57-473b-a31d-aecdcfc51ed0
Zobrazit plný text záznamu
9
Employment situation among long-term Hodgkin lymphoma survivors in Europe: an analysis of patients from nine consecutive EORTC-LYSA trials
Autor: Sidsel J. Juul, Sára Rossetti, Michal Kicinski, Marleen A. E. van der Kaaij, Francesco Giusti, Paul Meijnders, Berthe M. P. Aleman, John M. M. Raemaekers, Hanneke C. Kluin-Nelemans, Michele Spina, Christophe Fermé, Loïc Renaud, Olivier Casasnovas, Aspasia Stamatoullas, Marc André, Fabien Le Bras, Wouter J. Plattel, Michel Henry-Amar, Martin Hutchings, Maja V. Maraldo
Publikováno v: Journal of cancer survivorship
Journal of cancer survivorship : research and practice, (2022)
Purpose Little is known about the employment situation of long-term Hodgkin lymphoma (HL) survivors despite their young age at diagnosis and the favorable prognosis of the disease. In this cross-sectional study, we aim to describe the employment situ
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53184b709d7b04b964166a1168e345b8
https://doi.org/10.1007/s11764-022-01305-w
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje